Black Rock Inc. Evelo Biosciences, Inc. Transaction History

Black Rock Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.17 - $1.57 $13,138 - $121,340	-77,287 Reduced 6.27%	1,155,394 $207,000
Q4 2022 Feb 13, 2023	BUY	$1.44 - $48.2 $39,333 - $1.32 Million	27,315 Added 2.27%	1,232,681 $1.98 Million
Q3 2022 Nov 14, 2022	BUY	$1.86 - $41.8 $547,608 - $12.3 Million	294,413 Added 32.32%	1,205,366 $2.52 Million
Q2 2022 Aug 12, 2022	SELL	$1.46 - $3.55 $1.68 Million - $4.09 Million	-1,153,245 Reduced 55.87%	910,953 $1.92 Million
Q1 2022 May 12, 2022	SELL	$2.66 - $6.63 $114,752 - $286,018	-43,140 Reduced 2.05%	2,064,198 $7 Million
Q4 2021 Feb 10, 2022	BUY	$6.07 - $12.0 $1.62 Million - $3.21 Million	267,088 Added 14.51%	2,107,338 $12.8 Million
Q3 2021 Nov 09, 2021	SELL	$6.79 - $13.9 $22,081 - $45,202	-3,252 Reduced 0.18%	1,840,250 $13 Million
Q2 2021 Aug 11, 2021	BUY	$9.43 - $16.6 $17.4 Million - $30.6 Million	1,843,502 New	1,843,502 $25.3 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.